Huntington's disease - clinical signs, symptoms, presymptomatic diagnosis, and diagnosis

Handbook of Clinical Neurology

Volumn 100, Issue , 2011, Pages 3-13

  Shannon, Kathleen M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HD PROTEIN, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN;

BOOK; COGNITIVE DEFECT; DIAGNOSTIC IMAGING; DISABLED PERSON; DISEASE COURSE; GENETICS; HISTORY; HUMAN; HUNTINGTON CHOREA; METHODOLOGY; NEUROPHYSIOLOGY; ONSET AGE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; TRINUCLEOTIDE REPEAT;

AGE OF ONSET; COGNITION DISORDERS; DIAGNOSTIC IMAGING; DISABLED PERSONS; DISEASE PROGRESSION; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; HUNTINGTON DISEASE; NERVE TISSUE PROTEINS; NEUROPHYSIOLOGY; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 79954522581     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52014-2.00001-X     Document Type: Book

References (93)

1. Almqvist E.S., Adam M., Bloch A., et al. Risk reversals in predictive testing for Huntington disease. Am J Hum Genet 1997, 61:945-952.
2. Andrich J.L., Arning S., Wieczorek P., et al. Huntington's disease as caused by 34 CAG repeats. Mov Disord 2008, 23:879-881.
3. Anton G. Uber die Beteiligung der grossen basalen Gehirnganglien bei Bewegungsstorungen und insbesondere bei Chorea. Jahrbucher Psychiat Neurol (Lpz) 1896, 14:141-181.
4. Aubeeluck A., Brewer H. Huntington's disease. Part 2: treatment and management issues in juvenile HD. Br J Nurs 2008, 17:260-263.
5. Aylward E.H., Codori A.M., Barta P.E., et al. Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. Arch Neurol 1996, 53:1293-1296.
6. Aylward E.H., Codori A.M., Rosenblatt A., et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov Disord 2000, 15:552-560.
7. Becker W., Jurgens R., Kassubek J., et al. Eye-head coordination in moderately affected Huntington's disease patients: do head movements facilitate gaze shifts?. Exp Brain Res 2009, 192:97-112.
8. Blekher T., Weaver M.R., Marshall J., et al. Visual scanning and cognitive performance in prediagnostic and early-stage Huntington's disease. Mov Disord 2008, 24:533-540.
9. Brinkman R.R., Mezei M.M., Theilmann J., et al. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet 1997, 60:1202-1210.
10. Busse M.E., Wiles C.M., Rosser A.E. Mobility and falls in people with Huntington's disease. J Neurol Neurosurg Psychiatry 2009, 80:88-90.
11. Codori A.M., Slavney P.R., Young C., et al. Predictors of psychological adjustment to genetic testing for Huntington's disease. Health Psychol 1997, 16:36-50.
12. Cooper D.B., Ales G., Lange C., et al. Atypical onset of symptoms in Huntington disease: severe cognitive decline preceding chorea or other motor manifestations. Cogn Behav Neurol 2006, 19:222-224.
13. Costa Mdo C., Teixeira-Castro A., Constante M., et al. Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype. J Hum Genet 2006, 51:645-651.
14. de Boo G., Tibben A., Hermans J., et al. Subtle involuntary movements are not reliable indicators of incipient Huntington's disease. Mov Disord 1998, 13:96-99.
15. DeJong R.N. The history of Huntington's chorea in the United States of America. Adv Neurol 1973, 1:19-27.
16. Delval A., Krystkowiak P., Blatt J.L., et al. A biomechanical study of gait initiation in Huntington's disease. Gait Posture 2007, 25:279-288.
17. Delval A., Krystkowiak P., Delliaux M., et al. Role of attentional resources on gait performance in Huntington's disease. Mov Disord 2008, 23:684-689.
18. Etchegary H. Genetic testing for Huntington's disease: how is the decision taken?. Genet Test 2006, 10:60-67.
19. Folstein S.E., Leigh R.J., Parhad I.M., et al. The diagnosis of Huntington's disease. Neurology 1986, 36:1279-1283.
20. Gambardella A., Muglia M., Labate A., et al. Juvenile Huntington's disease presenting as progressive myoclonic epilepsy. Neurology 2001, 57:708-711.
21. Georgiou-Karistianis N., Hoy K.E., Bradshaw J.L., et al. Motor overflow in Huntington's disease. J Neurol Neurosurg Psychiatry 2004, 75:904-906.
22. Goizet C., Lesca G., Durr A. Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias. Neurology 2002, 59:1330-1336.
23. Gomez-Tortosa E., del Barrio A., Garcia Ruiz P.J., et al. Severity of cognitive impairment in juvenile and late-onset Huntington disease. Arch Neurol 1998, 55:835-843.
24. Gonzalez-Alegre P., Afifi A.K. Clinical characteristics of childhood-onset (juvenile) Huntington disease: report of 12 patients and review of the literature. J Child Neurol 2006, 21:223-229.
25. Grimbergen Y.A., Knol M.J., Bloem B.R., et al. Falls and gait disturbances in Huntington's disease. Mov Disord 2008, 23:970-976.
26. Gusella J.F., Wexler N.S., Conneally P.M., et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983, 306:234-238.
27. Hansotia P., Cleeland C.S., Chun R.W. Juvenile Huntington's chorea. Neurology 1968, 18:217-224.
28. Harbinson A. Sclerosis of the nervous centres, mainly cerebral. Med Press Circular 1880, 29:123-125.
29. Hennerici M., Homberg V., Lange H.W. Evoked potentials in patients with Huntington's disease and their offspring. II. Visual evoked potentials. Electroencephalogr Clin Neurophysiol 1985, 62:167-176.
30. Hicks S.L., Robert M.P., Golding C.V., et al. Oculomotor deficits indicate the progression of Huntington's disease. Prog Brain Res 2008, 171:555-558.
31. Ho A.K., Sahakian B.J., Brown R.G., et al. Profile of cognitive progression in early Huntington's disease. Neurology 2003, 61:1702-1706.
32. Ho A.K., Robbins A.O., Barker R.A. Huntington's disease patients have selective problems with insight. Mov Disord 2006, 21:385-389.
33. Hoth K.F., Paulsen J.S., Moser D.J., et al. Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities. J Clin Exp Neuropsychol 2007, 29:365-376.
34. Huntington G. On chorea. Med Surg Rep 1872, 26:320-321.
35. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea Guidelines for the molecular genetics predictive test in Huntington's disease. Neurology 1994, 44:1533-1536.
36. Jacopini G.A., D'Amico R., Frontali M., et al. Attitudes of persons at risk and their partners toward predictive testing. Birth Defects Orig Artic Ser 1992, 28:113-117.
37. Jankovic J., Ashizawa T. Tourettism associated with Huntington's disease. Mov Disord 1995, 10:103-105.
38. Jankovic J., Lang A.E. Movement disorders: diagnosis and assessment. Neurology in Clinical Practice 2008, 293-326. Butterworth Heineman Elsevier, Philadelphia. 5th edn. W.G. Bradley, R.B. Daroff, G.M. Fenichel (Eds.).
39. Johnson S.A., Stout J.C., Solomon A.C., et al. Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease. Brain 2007, 130:1732-1744.
40. Kagel M.C., Leopold N.A. Dysphagia in Huntington's disease: a 16-year retrospective. Dysphagia 1992, 7:106-114.
41. Keckarevic D., Culjkovic B., Savic D., et al. The status of SCA1, MJD/SCA3, FRDA, DRPLA and MD triplet containing genes in patients with Huntington disease and healthy controls. J Neurogenet 2000, 14:257-263.
42. Kenney C., Powell S., Jankovic J. Autopsy-proven Huntington's disease with 29 trinucleotide repeats. Mov Disord 2007, 22:127-130.
43. Koller W.C., Trimble J. The gait abnormality of Huntington's disease. Neurology 1985, 35:1450-1454.
44. Langbehn D.R., Paulsen J.S. Predictors of diagnosis in Huntington disease. Neurology 2007, 68:1710-1717.
45. Lange K.W., Sahakian B.J., Quinn N.P., et al. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry 1995, 58:598-606.
46. Lanska D.J., Lanska M.J., Lavine L., et al. Conditions associated with Huntington's disease at death. A case-control study. Arch Neurol 1988, 45:878-880.
47. Lefaucheur J.P., Bachoud-Levi A.C., Bourdet C., et al. Clinical relevance of electrophysiological tests in the assessment of patients with Huntington's disease. Mov Disord 2002, 17:1294-1301.
48. Lefaucheur J.P., Menard-Lefaucheur I., Maison P., et al. Electrophysiological deterioration over time in patients with Huntington's disease. Mov Disord 2006, 21:1350-1354.
49. Louis E.D., Lee P., Quinn L., et al. Dystonia in Huntington's disease: prevalence and clinical characteristics. Mov Disord 1999, 14:95-101.
50. Louis E.D., Anderson K.E., Moskowitz C., et al. Dystonia-predominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults. Arch Neurol 2000, 57:1326-1330.
51. Ludlow C.L., Connor N.P., Bassich C.J. Speech timing in Parkinson's and Huntington's disease. Brain Lang 1987, 32:195-214.
52. Lund J.C. Beretning om Sundhedstilstanden og. Medicial forholdene in Norge 1860, 4:137.
53. Lyon J.W. Chronic hereditary chorea. Am Med Times 1863, 7:289-290.
54. Mastromauro C., Myers R.H., Berkman B. Attitudes toward presymptomatic testing in Huntington disease. Am J Med Genet 1987, 26:271-282.
55. Meiser B., Gleeson M.A., Tucker K.M. Psychological impact of genetic testing for adult-onset disorders. An update for clinicians. Med J Aust 2000, 172:126-129.
56. Mohr E., Brouwers P., Claus J.J., et al. Visuospatial cognition in Huntington's disease. Mov Disord 1991, 6:127-132.
57. Nance M.A. Genetic testing of children at risk for Huntington's disease. US Huntington Disease Genetic Testing Group. Neurology 1997, 49:1048-1053.
58. Nance M.A., Myers R.H. Juvenile onset Huntington's disease - clinical and research perspectives. Ment Retard Dev Disabil Res Rev 2001, 7:153-157.
59. Nance M.A., Sanders G. Characteristics of individuals with Huntington disease in long-term care. Mov Disord 1996, 11:542-548.
60. Negrette A. Corea de Huntington 1962, Falcutad de Medicine, Universidad del Zulia, Maracaibo.
61. Okun M.S., Thommi N. Americo Negrette (1924 to 2003): diagnosing Huntington disease in Venezuela. Neurology 2004, 63:340-343.
62. Oliver J., Dewhurst K. Childhood and adolescent forms of Huntington's disease. J Neurol Neurosurg Psychiatry 1969, 32:455-459.
63. Osler W. On chorea and choreiform affections 1894, P. Blakiston, Philadelphia.
64. Osler W. Historical note on hereditary chorea. Neurographs 1908, 1:113-116.
65. Paulsen J.S., Conybeare R.A. Cognitive changes in Huntington's disease. Adv Neurol 2005, 96:209-225.
66. Paulsen J.S., Langbehn D.R., Stout J.C., et al. Detection of Huntington's disease decades before diagnosis: The Predict HD study. J Neurol Neurosurg Psychiatry 2008, 79:874-880.
67. Peltsch A., Hoffman A., Armstrong I., et al. Saccadic impairments in Huntington's disease. Exp Brain Res 2008, 186:457-469.
68. Ramig L.A. Acoustic analyses of phonation in patients with Huntington's disease. Preliminary report. Ann Otol Rhinol Laryngol 1986, 95:288-293.
69. Ramos-Arroyo M.A., Moreno S., Valiente A. Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing. J Neurol Neurosurg Psychiatry 2005, 76:337-342.
70. Rao A.K., Muratori L., Louis E.D., et al. Spectrum of gait impairments in presymptomatic and symptomatic Huntington's disease. Mov Disord 2008, 23:1100-1107.
71. Ravina B., Romer M., Constantinescu R., et al. The relationship between CAG repeat length and clinical progression in Huntington's disease. Mov Disord 2008, 23:1223-1227.
72. Ribai P., Nguyen K., Hahn-Barma V., et al. Psychiatric and cognitive difficulties as indicators of juvenile Huntington disease onset in 29 patients. Arch Neurol 2007, 64:813-819.
73. Sharma P., Savy L., Britton J., et al. Huntington's disease: a molecular genetic and CT comparison. J Neurol Neurosurg Psychiatry 1996, 60:206-208.
74. Snowden J.S., Craufurd D., Griffiths H.L., et al. Awareness of involuntary movements in Huntington disease. Arch Neurol 1998, 55:801-805.
75. Stevanin G., Brice A. Spinocerebellar ataxia 17 (SCA17) and Huntington's disease-like 4 (HDL4). Cerebellum 2008, 7:170-178.
76. Tassicker R.J., Teltscher B., Trembath M.K., et al. Problems assessing uptake of Huntington disease predictive testing and a proposed solution. Eur J Hum Genet 2009, 17:66-70.
77. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
78. The US-Venezuela Collaborative Research Project, Wexler N. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. PNAS 2004, 101:3498-3503.
79. Thompson P.D., Bhatia K.P., Brown P., et al. Cortical myoclonus in Huntington's disease. Mov Disord 1994, 9:633-641.
80. Tian J., Herdman S.J., Zee D.S., et al. Postural stability in patients with Huntington's disease. Neurology 1992, 42:1232-1238.
81. Tibben A., Duivenvoorden H.J., Vegter-van der Vlis M., et al. Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention. Am J Med Genet 1993, 48:137-144.
82. Tibben A., Timman R., Bannink E.C., et al. Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners. Health Psychol 1997, 16:20-35.
83. van der Steenstraten I.M., Tibben A., Roos R.A., et al. Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. Am J Hum Genet 1994, 55:618-625.
84. van Vugt J.P., Piet K.K., Vink L.J., et al. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up. Mov Disord 2004, 19:285-297.
85. Verny C., Allain P., Prudean A., et al. Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene. Eur J Neurol 2007, 14:1344-1350.
86. Walker F.O. Huntington's Disease. Semin Neurol 2007, 27:143-150.
87. Waters C.O. Description of chorea. Practice of Medicine 1842, 312-313. Lea & Blanchard, Philadelphia. R. Dunglison (Ed.).
88. Westphal C. Uber eine dem Bilde der cerebrospinalen grauen Degeneraton ahnliche Erkrankung des zentralen Nervensystems ohne anatomischen Befund, nebst, einigen Bemerkunger uber Paradoxe Kontraktion. Arch Psych Nervenkr 1883, 14:87-96.
89. Wheelock V.L., Tempkin T., Marder K., et al. Predictors of nursing home placement in Huntington disease. Neurology 2003, 60:998-1001.
90. Wild E.J., Mudanohwo E.E., Sweeney M.G., et al. Huntington's disease phenocopies are clinically and genetically heterogeneous. Mov Disord 2008, 23:716-720.
91. Yoon G., Kramer J., Zanko A., et al. Speech and language delay are early manifestations of juvenile-onset Huntington disease. Neurology 2006, 67:1265-1267.
92. Young A.B., Shoulson I., Penney J.B., et al. Huntington's disease in Venezuela: neurologic features and functional decline. Neurology 1986, 36:244-249.
93. Zakzanis K.K. The subcortical dementia of Huntington's disease. J Clin Exp Neuropsychol 1998, 20:565-578.